PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Virology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.\', \'Division of Hematology, Department of Translational Medicine, University of Piemonte Orientale and \'Maggiore della Carità\' Hospital, Novara, Italy.\', \'CAAD Center for Translational Research on Autoimmune and Allergic Disease, Novara, Italy.\', \'Viral Pathogenesis Unit, Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.\', \'Medical Statistics, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.\', \'Division of Hematology, University of Piemonte Orientale and \'SS Antonio e Biagio e Cesare Arrigo\' Hospital, Alessandria, Italy.\', \'Division of Hematology, \'Santa Croce e Carle di Cuneo\' Hospital, Cuneo, Italy.\', \'Retrovirus Centre, Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.\', \'Virology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy. marisa.gariglio@med.uniupo.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41408-022-00608-6
?:hasPublicationType
?:journal
  • Blood cancer journal
is ?:pmid of
?:pmid
?:pmid
  • 35042847
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.727
?:rankingScore_hIndex
  • 30
?:title
  • Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all